According to Evoke Pharma 's latest financial reports the company's current EPS (TTM) is -ยฃ1.80. In 2022 the company made an earnings per share (EPS) of -ยฃ2.02 an increase over its 2021 EPS that were of -ยฃ2.41.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -ยฃ1.96 | -2.82% |
2022 | -ยฃ2.02 | -16.19% |
2021 | -ยฃ2.41 | -49.52% |
2020 | -ยฃ4.77 | 57.58% |
2019 | -ยฃ3.03 | -28.26% |
2018 | -ยฃ4.22 | -45.24% |
2017 | -ยฃ7.70 | -33.86% |
2016 | -ยฃ11.64 | -32.8% |
2015 | -ยฃ17.33 | -13.7% |
2014 | -ยฃ20.08 | 65.26% |
2013 | -ยฃ12.15 | -25.35% |
2012 | -ยฃ16.28 |